Eli Lilly Sues Telehealth Companies, Alleging Corporate Practice of Medicine Violations

Eli Lilly and Company has initiated a series of lawsuits against telehealth companies, alleging their business practices constitute the corporate practice of medicine. The pharmaceutical giant claims these firms are overstepping legal boundaries by engaging in activities traditionally reserved for licensed medical professionals. The lawsuits center on Lilly’s assertion that telehealth companies are making medical decisions without proper physician oversight. Specifically, the company alleges these firms are prescribing medications, including those manufactured by Lilly, in a manner that violates state laws prohibiting the corporate practice of medicine. These laws are designed to prevent business entities from interfering with the independent medical judgment of doctors and to ensure patient care remains the primary focus. The outcomes of these legal challenges could significantly impact the operational models of telehealth providers and the broader landscape of virtual healthcare services.

Newsflash | Powered by GeneOnline AI
Date: April 23, 2025

Related posts:

Study Reveals Cognitive Decline Linked to Low-Normal Vitamin B12 Levels Roger Perlmutter’s New Biotech Startup Secures $350 Million in Funding Breakthrough in Cancer Vaccine Development Enhances Effectiveness and Reach Anne Wojcicki’s Bold Move to Reclaim 23andMe Sparks Debate in Biotech Industry

Author

Mark Chiang

紐約 NYU Computer Science 碩士 紐澤西 UMDNJ Biomedical Informatics 博士 中研院博士後 台灣大學博士後